Mullennix Stephen 4
4 · UroGen Pharma Ltd. · Filed Nov 18, 2019
Insider Transaction Report
Form 4
Mullennix Stephen
Chief Operating Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2019-11-14+1,759→ 8,291 total - Exercise/Conversion
Restricted Stock Units
2019-11-14−1,759→ 8,796 total→ Ordinary Shares (1,759 underlying) - Sale
Ordinary Shares
2019-11-14$26.00/sh−608$15,806→ 7,683 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
- [F2]Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- [F3]The reporting person was granted restricted stock units ("RSUs") on March 7, 2018, June 4, 2018 and October 28, 2018 representing 21,107 ordinary shares in the aggregate. 1/3rd of the RSUs vested on February 14, 2019, with the balance vesting in equal quarterly installments thereafter over a period of two years.